Raimondo Di Liello

Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures

Carminia Maria Della Corte, Giusi Barra, Vincenza Ciaramella et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 105 citations · Full text

Medicine, Immunology, Oncology +17

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer

Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte et al. · ESMO Open · 2017 · 76 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

Maria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino et al. · Journal of Thoracic Oncology · 2022 · 68 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +9

Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC

Vincenza Ciaramella, Ferdinando Carlo Sasso, Raimondo Di Liello et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 52 citations · Full text

Medicine, Cancer Biology, Pharmacology +16

Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: case report and translational study

Raimondo Di Liello, Vincenza Ciaramella, Giusi Barra et al. · ESMO Open · 2019 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17